"Ospedale di Alta Specialità a Rapallo, in provincia di Genova, accreditato con il Servizio Sanitario Nazionale. Per maggiori informazioni e prenotazioni visita il sito web."

During the past decade, ICLAS Rapallo conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "ICLAS Rapallo" #1 collaborator was "Ettore Sansavini Health Science Foundation" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "ICLAS Rapallo" are "C.Surgical Procedure; Cardiac" (1 trials), "PAD" (1 trials), "Peripheral Artery Disease" (1 trials) and "Tricuspid (Valve) Insufficiency (Rheumatic)" (1 trials). Many other conditions were trialed in "ICLAS Rapallo" in a lesser frequency.

Most popular intervention types in "ICLAS Rapallo" are "Device" (2 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Conventional CPB" (1 trials), "Drug Coated Balloon" (1 trials), "EVADO" (1 trials), "Mitral valve surgery" (1 trials) and "Tricuspid valve annuloplasty" (1 trials). Other intervention names were less common.

The vast majority of trials in "ICLAS Rapallo" are 4 trials for "All" genders.

Currently, there are NaN active trials in "ICLAS Rapallo". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in ICLAS Rapallo, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in ICLAS Rapallo, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".